Custom Antibody Production Service
End-to-End Antibody Development Services for Research, Diagnostic, and Therapeutic Applications
BioCrest Sci provides custom antibody production services for academic laboratories, biotechnology companies, diagnostic developers, and pharmaceutical research teams. We support multiple antibody generation platforms to help researchers obtain antibodies optimized for specific experimental goals, assay formats, and downstream development requirements.
Our antibody customization services are built on 18 years of protein and antibody expertise, with a focus on transparency, reproducibility, and scientific rigor — not overpromised success rates.
Our Antibody Customization Services
Select the service that matches your project needs. Each option below leads to a dedicated service page with detailed workflows, timelines, and technical specifications.
Custom Monoclonal Antibody
Custom Polyclonal Antibody
Custom Recombinant Antibody
Custom Nanobody (VHH)
Neutralizing Antibody
Comparison of Antibody Production Platforms
| Service Type | Main Advantages | Typical Timeline | Best-Fit Applications |
|---|---|---|---|
| Polyclonal Antibody | Fast and broad epitope recognition | ~2–4 months | WB, ELISA, exploratory studies |
| Monoclonal Antibody | Specificity and reproducibility | ~3–6 months | Diagnostics, flow cytometry, IHC |
| Recombinant Antibody | Sequence-defined renewable reagent | ~1–3 months after sequence | Therapeutic and engineered antibody research |
| Nanobody (VHH) | Small size and high stability | ~3–5 months | Imaging, intracellular targeting, CAR research |
| Neutralizing Antibody | Functional biological inhibition | Variable | Antiviral and blocking studies |
Antibody Applications We Support
Our custom antibodies are developed with your downstream applications in mind, including:
| Application Area | Examples |
|---|---|
| Immunoassays | ELISA, sandwich ELISA, MSD |
| Protein detection | Western blot, immunoprecipitation (IP) |
| Cell-based assays | Flow cytometry, immunofluorescence (IF/ICC) |
| Tissue analysis | Immunohistochemistry (IHC) |
| Functional studies | Neutralization assays, receptor blocking |
| Biomarker work | Biomarker validation, protein functional analysis |
| Therapeutic research | Antibody screening, cell therapy, infectious disease studies |
Antigen Types Supported
We support antibody generation against a broad range of antigen classes:
Recombinant proteins
Peptides (including phosphorylated)
Membrane proteins
GPCRs and ion channels
Cytokines and growth factors
Viral and bacterial antigens
Toxins
Fusion proteins
Haptens and small molecules
Our scientists can assist with epitope selection, antigen design, peptide synthesis strategy, conjugation planning, and immunization optimization before your project starts.
Screening & Validation Options
Antibody performance varies across assay formats. We offer customizable screening aligned with your intended application:
| Validation Method | Typical Purpose |
|---|---|
| ELISA | Binding screening |
| Western blot | Denatured protein recognition |
| Flow cytometry | Cell surface binding |
| Immunofluorescence (IF/ICC) | Cellular localization |
| Immunohistochemistry (IHC) | Tissue staining |
| Neutralization assays | Functional inhibition |
| SPR / BLI | Affinity characterization |
| Pair screening | Sandwich assay development |
| Cell-based assays | Functional activity analysis |
Quality Control & Scientific Transparency
Antibody discovery is a biological process influenced by antigen quality, immunogenicity, screening strategy, and assay requirements. Not every project generates antibodies with identical performance across all applications.
We do not claim 100% success. Instead, we provide:
Antigen integrity assessment
Serum titer monitoring
Clone stability testing
Contamination screening
Sequence verification (for recombinant antibodies)
Purification QC (SDS-PAGE, endotoxin, concentration)
Application-specific validation where feasible
If a strategy is unlikely to succeed, we will tell you upfront and recommend an alternative approach.
Why Researchers Choose BioCrest Sci for Antibody Customization
| Feature | What It Means For You |
|---|---|
| Multiple platforms | Monoclonal, polyclonal, recombinant, nanobody, and neutralizing — all in one place |
| Application-oriented screening | Validation tailored to your downstream assay, not generic testing |
| Difficult target expertise | Membrane proteins, conformational epitopes, phospho-targets, viral proteins, low-immunogenicity antigens |
| Transparent communication | Weekly updates, raw data access, and honest feasibility assessments |
| Flexible project scope | From exploratory generation to engineered and functional antibodies |
Frequently Asked Questions
Which antibody platform is best for my project?
It depends on your antigen, timeline, downstream application, and whether you need recombinant or functional antibodies. Our scientists can help evaluate the best strategy before you commit.
Can you generate antibodies against membrane proteins?
Yes. We support peptide immunization, recombinant extracellular domains, cell-based immunization, and recombinant screening workflows for membrane targets.
Do you offer antibody sequencing and recombinant recovery?
Yes. These services can be integrated into monoclonal, nanobody, and recombinant antibody workflows.
Can antibodies be screened for neutralizing activity?
Yes. Functional screening workflows can be designed for receptor blocking, viral neutralization, ligand inhibition, and related biological assays.
Start Your Custom Antibody Production Project
If you are planning an antibody discovery or custom antibody generation program, BioCrest Sci can help evaluate antigen strategy, platform selection, screening design, and downstream application requirements.
Contact our scientific team to discuss your custom antibody production project and technical development goals — no obligation, just a scientist-to-scientist conversation.
[Request a Technical Consultation →]